This Medudy course is a video tutorial for physicians on the topic of "Hormone therapy and its impact on Alzheimer's disease". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
It is projected that 13.8 million Americans will develop Alzheimer's disease by 2060, nearly two-thirds of whom will be women. This gender disparity may be related to earlier and faster tau pathology in women, which may be influenced by menopause. The symptoms associated with menopause can be effectively treated with hormone therapy, but the effects on the brain remain controversial. Today's study therefore used PET imaging to investigate the extent to which the use of menopausal hormone therapy is associated with the accumulation of amyloid-β and tau in later life.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
At the end of this training you will know:
- the clinical background and relevance of the research question under investigation
- Study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
